Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus

被引:14
作者
Mito, N
Hiyoshi, T
Hosoda, T
Kitada, C
Sato, K
机构
[1] Japan Womens Univ, Div Clin Nutr, Bunkyo Ku, Tokyo 1128681, Japan
[2] Japanese Red Cross Med Ctr, Tokyo, Japan
关键词
obesity; immunity; insulin;
D O I
10.1038/sj.ejcn.1601324
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: To understand the effect of obesity and insulin on immune functions in non-insulin-dependent diabetes mellitus (NIDDM). Subject: Fourteen obese NIDDM (body mass index (BMI) = 30.6 +/- 1.1), seven non-obese NIDDM (BMI = 24.2 +/- 0.5) and five obese non-NIDDM (BMI = 28.3 +/- 0.67). Interventions: We first examined the influence of insulin on the proliferation of several human cell lines. Second, we compared several immune functions between obese and non-obese NIDDM, and obese non-NIDDM patients using peripheral blood mononuclear cells. Result: Insulin decreased proliferation of T-cell lines but not that of other types of cell lines. Furthermore, obesity augmented the production of IL-1beta which could have cytotoxity against islet beta cells in NIDDM. Conclusion: Our data suggested that the pathophysiology of NIDDM could be affected by the change of immunity due to obesity, and the treatment of obesity in NIDDM may be important from an immunological aspect.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 29 条
[1]  
BRINKMANN V, 1995, J IMMUNOL, V155, P3322
[2]   Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients [J].
Bunout, D ;
Munoz, C ;
Lopez, M ;
delaMaza, MP ;
Schlesinger, L ;
Hirsch, S ;
Pettermann, M .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 63 (03) :373-376
[3]   IN-VITRO SECRETION OF INTERLEUKIN-1-BETA AND INTERFERON-GAMMA BY PERIPHERAL-BLOOD LYMPHOMONONUCLEAR CELLS IN DIABETIC-PATIENTS [J].
CIAMPOLILLO, A ;
GUASTAMACCHIA, E ;
CARAGIULO, L ;
LOLLINO, G ;
DEROBERTIS, O ;
LATTANZI, V ;
GIORGINO, R .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 21 (2-3) :87-93
[4]   Increased expression of tumor necrosis factor-α in diabetic macrovasculopathy [J].
Clausell, N ;
Kalil, P ;
Biolo, A ;
Molossi, S ;
Azevedo, M .
CARDIOVASCULAR PATHOLOGY, 1999, 8 (03) :145-151
[5]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[6]   Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications -: The effect of α-tocopherol supplementation [J].
Devaraj, S ;
Jialal, I .
CIRCULATION, 2000, 102 (02) :191-196
[7]  
DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413
[8]   CURRENT CONCEPTS - LYMPHOKINES [J].
DINARELLO, CA ;
MIER, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (15) :940-945
[9]  
FENGYEE C, 1995, DIABETES RES CLIN PR, V28, P137
[10]   LEPTIN LEVELS REFLECT BODY LIPID-CONTENT IN MICE - EVIDENCE FOR DIET-INDUCED RESISTANCE TO LEPTIN ACTION [J].
FREDERICH, RC ;
HAMANN, A ;
ANDERSON, S ;
LOLLMANN, B ;
LOWELL, BB ;
FLIER, JS .
NATURE MEDICINE, 1995, 1 (12) :1311-1314